← Back to Clinical Trials
Recruiting NCT07196007

NCT07196007 Leveraging Community-clinical Linkages to Address Unmet Social Needs for People With Diabetes

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07196007
Status Recruiting
Phase
Sponsor Mary Lacy
Condition Diabetes
Study Type INTERVENTIONAL
Enrollment 12,000 participants
Start Date 2026-03-10
Primary Completion 2027-03

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Community-Clinical Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 12,000 participants in total. It began in 2026-03-10 with a primary completion date of 2027-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is a hybrid type 2 design to evaluate the effectiveness and implementation of a community-clinical linkage intervention in primary clinics to address unmet social needs for patients with diabetes living in rural communities. The study will take place in two rural communities in Kentucky, one in eastern Kentucky and one in western Kentucky.

Eligibility Criteria

Clinic/Staff Inclusion Criteria: * staff at the intervention or comparison clinic Participant Inclusion Criteria: * age 18 or older, * is a patient at the intervention or comparison clinic * diagnosed with diabetes Clinic/Staff Exclusion Criteria: * staff not at the intervention or comparison clinic Participant Exclusion Criteria: * being under the age of 18, * not a patient at the intervention or comparison clinic * not diagnosed with diabetes

Contact & Investigator

Central Contact

Carol R White, MPH

✉ crwhit3@uky.edu

📞 859-562-2684

Principal Investigator

Beth Lacy Leigh

PRINCIPAL INVESTIGATOR

University of Kentucky

Frequently Asked Questions

Who can join the NCT07196007 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07196007 currently recruiting?

Yes, NCT07196007 is actively recruiting participants. Contact the research team at crwhit3@uky.edu for enrollment information.

Where is the NCT07196007 trial being conducted?

This trial is being conducted at Lexington, United States.

Who is sponsoring the NCT07196007 clinical trial?

NCT07196007 is sponsored by Mary Lacy. The principal investigator is Beth Lacy Leigh at University of Kentucky. The trial plans to enroll 12,000 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology